109 related articles for article (PubMed ID: 6580896)
21. Diffuse vascular spasm associated with 4-bromo-2,5-dimethoxyamphetamine ingestion.
Bowen JS; Davis GB; Kearney TE; Bardin J
JAMA; 1983 Mar; 249(11):1477-9. PubMed ID: 6827726
[No Abstract] [Full Text] [Related]
22. [Determination of 4-bromo-2,5-dimethoxyamphetamine (DOB) found in illicit tablets seized in Italy].
Furnari C; Ottaviano V; Rosati F
Ann Ist Super Sanita; 2001; 37(2):297-300. PubMed ID: 11758288
[TBL] [Abstract][Full Text] [Related]
23. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.
Buchborn T; Schröder H; Dieterich DC; Grecksch G; Höllt V
Behav Brain Res; 2015 Mar; 281():62-8. PubMed ID: 25513973
[TBL] [Abstract][Full Text] [Related]
24. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
Callahan PM; Appel JB
J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
[TBL] [Abstract][Full Text] [Related]
25. Hallucinogen Use Disorders.
Hardaway R; Schweitzer J; Suzuki J
Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):489-96. PubMed ID: 27338969
[TBL] [Abstract][Full Text] [Related]
26. The use of rigid analogues to probe hallucinogen receptors.
Nichols DE; Weintraub HJ; Pfister WR; Yim GK
NIDA Res Monogr; 1978; (22):70-83. PubMed ID: 101889
[No Abstract] [Full Text] [Related]
27. Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.
Licht CL; Christoffersen M; Okholm M; Damgaard L; Fink-Jensen A; Knudsen GM; Erritzoe D
Hum Psychopharmacol; 2012 Jul; 27(4):352-63. PubMed ID: 22696164
[TBL] [Abstract][Full Text] [Related]
28. Congeners of DOM: effect of distribution of the evaluation of pharmacologic data.
Barfknecht CF; Caputo JF; Tobin MB; Dyer DC; Standirdge RT; Howell HG; Goodwin WR; Partyka RA; Gylys JA; Cavanagh RL
NIDA Res Monogr; 1978; (22):16-26. PubMed ID: 101880
[No Abstract] [Full Text] [Related]
29. Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision.
Hendricks PS; Clark CB; Johnson MW; Fontaine KR; Cropsey KL
J Psychopharmacol; 2014 Jan; 28(1):62-6. PubMed ID: 24399338
[TBL] [Abstract][Full Text] [Related]
30. First case report of recreational use of 2,5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening.
Ovaska H; Viljoen A; Puchnarewicz M; Button J; Ramsey J; Holt DW; Dargan PI; Wood DM
Eur J Emerg Med; 2008 Dec; 15(6):354-6. PubMed ID: 19078842
[TBL] [Abstract][Full Text] [Related]
31. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
32. Neurological aspects of hallucinogenic drugs.
Logan WJ
Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
[No Abstract] [Full Text] [Related]
33. [Synesthesias in the context of hallucinogen-induced persistent perception disorder following the use of lsd].
Neven A; Blom JD
Tijdschr Psychiatr; 2014; 56(11):748-52. PubMed ID: 25401683
[TBL] [Abstract][Full Text] [Related]
34. [Hallucinogens, amphetamines and entactogens].
Vollenweider FX; Vollenweider-Scherpenhuyzen MF
Ther Umsch; 2003 Jun; 60(6):323-8. PubMed ID: 12848067
[TBL] [Abstract][Full Text] [Related]
35. GC-MS and GC-IRD studies on brominated dimethoxyamphetamines: regioisomers related to 4-Br-2,5-DMA (DOB).
Maher HM; Awad T; DeRuiter J; Randall Clark C
Drug Test Anal; 2012; 4(7-8):591-600. PubMed ID: 22389110
[TBL] [Abstract][Full Text] [Related]
36. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
Pierce PA; Peroutka SJ
J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of substituted-amphetamine hallucinogens using the cat limb flick model.
Rusterholz DB; Spratt JL; Long JP; Barfknecht CF
Commun Psychopharmacol; 1977; 1(6):589-92. PubMed ID: 608329
[No Abstract] [Full Text] [Related]
38. [Hallucinogen-induced psychological disorders].
Hermle L; Kovar KA; Hewer W; Ruchsow M
Fortschr Neurol Psychiatr; 2008 Jun; 76(6):334-42. PubMed ID: 18512184
[TBL] [Abstract][Full Text] [Related]
39. MDA--another stupefacente.
Mack RB
N C Med J; 1982 Nov; 43(11):777-8. PubMed ID: 6960259
[No Abstract] [Full Text] [Related]
40. QSAR studies on psychotomimetic phenylalkylamines.
Gupta SP; Handa A; Bindal MC; Singh P
Arzneimittelforschung; 1983; 33(8):1089-90. PubMed ID: 6685483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
